Haute Protection High Protection Tinted Compact Broad Spectrum Spf 50 Honey Cream
NDC Package 67015-2035-1
Package Information
Haute Protection High Protection Tinted Compact Broad Spectrum Spf 50 Honey (titanium dioxide, zinc oxide) cream is apply liberally/generously and evenly15 minutes before sun exposure.Reapply:after 40 minutes of swimming or sweatingimmediately after towel dryingat least every 2 hours.Children under 6 months: Consult a health care practitioner.Sun Protection Measures: Spending time in the sun increases your risk of skin cancer and early skin aging. This formulation utilizes a cream delivery system. Marketed by Pierre Fabre Usa Inc., this product is identified by NDC 67015-2035 and is authorized under FDA application M020.
Identification & Billing
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 67015 - Pierre Fabre Usa Inc.
- 67015-2035 - Haute Protection High Protection Tinted Compact Broad Spectrum Spf 50 Honey
- 67015-2035-1 - 1 CONTAINER in 1 CARTON / 10 g in 1 CONTAINER (67015-2035-0)
- 67015-2035 - Haute Protection High Protection Tinted Compact Broad Spectrum Spf 50 Honey
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 67015-2035-1 identifies a specific commercial package of 1 container in 1 carton / 10 g in 1 container (67015-2035-0) of Haute Protection High Protection Tinted Compact Broad Spectrum Spf 50 Honey, a human over the counter drug labeled by Pierre Fabre Usa Inc.. This cream is formulated for topical use and contains titanium dioxide; zinc oxide as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Pierre Fabre Usa Inc. on June 03, 2019. The current certification is valid through December 31, 2026.
How is this Pierre Fabre Usa Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 67015203501. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Package segment to maintain the 5-4-2 structure.